MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Neurophenomenological Aspects of Monocular Visual Hallucinations in Charles Bonnet Syndrome in a patient with Parkinson’s Disease

    D. Nolasco, A. Makarem, B. Buchowicz, L. Schmidt, B. Carr (Gainesville, USA)

    Objective: This inquiry aims to augment understanding of Charles Bonnet Syndrome (CBS) by scrutinizing both monocular and bilateral visual hallucinations. It focuses on an atypical…
  • 2024 International Congress

    Predictors of Response to Botulinum Toxin Treatment in Patients With Hemifacial Spasm:A Prospective Study

    S. Jain, S. Pandey, RK. Garg, HS. Malhotra, I. Rizvi (Lucknow, India)

    Objective: To study the predictors of Good and Bad outcome and the impact on quality of life of patients with HFS following Botulinum toxin treatment.…
  • 2024 International Congress

    Tremors Vs. Tremors: the first music album from Parkinson’s tremors

    C. Dore, J. Thomas, S. Rose, J. Leitão, C. Hugill, C. Lambert (London, United Kingdom)

    Objective: Tremors Vs. Tremors is a creative engagement project exploring the intersection between music, mood and tremor. The objective was to raise awareness of Parkinson’s…
  • 2024 International Congress

    Co-morbid Hypertension and Diabetes and the Relationship to Parkinson’s Disease Motor Phenotype in the Nigeria Parkinson’s Disease Research Network Registry

    E. Iwuozo, O. Ojo, O. Agabi, N. Okubadejo, NPD. Research Network (Makurdi, Nigeria)

    Objective: To determine the frequency of hypertension (HBP) and type 2 diabetes mellitus (T2DM) as comorbidities in the Nigerian PD Research network (NPDR) cohort, and…
  • 2024 International Congress

    Altered levels of interleukin-6 in Parkinson’s disease patients with and without Covid-19

    R. Matmurodov, B. Muminov, K. Khalimova (Tashkent, Uzbekistan)

    Objective: Comparison of serum IL-6 levels in Parkinson's disease (PD) patients with and without Сovid-19. Background: Scientists say that the infectious agent SARS-CoV-2 increases the…
  • 2024 International Congress

    Levels of change in interleukin-6 levels according to clinical forms of Parkinson’s disease in patients with and without Covid-19

    B. Muminov, R. Matmurodov (Tashkent, Uzbekistan)

    Objective: Comparison of serum IL-6 levels in clinical forms Parkinson's disease (PD) patients with and without Сovid-19. Background: Changes in the treatment after infection with…
  • 2024 International Congress

    Movement Disorders in the Emergency:New Insights

    A. Banik, D. Manna, S. Pal, A. Chakravarty, I. Dutta, A. Chattopadhyay, S. Banerjee (kolkata, India)

    Objective: The study objective was to assess the clinico-epidemiological aspects of patients attending the Emergency with movement disorder as the primary symptom. Background: Available literature…
  • 2024 International Congress

    Preventing Medication Errors for Hospitalized People with Parkinson’s Disease – Results of Six Months of Proactive Intervention

    C. Piccinin, J. Yu, A. Brooks, V. Stepanyants, P. Clark, S. Shaffer, B. Sokola, K. Lewin, C. Sonneborn, O. Hogue, S. Sperling, H. Fernandez, W. Walter (Cleveland, USA)

    Objective: To determine whether a Parkinson’s disease (PD) Inpatient Program will prevent medication errors and ultimately improve the safety and quality of care for hospitalized…
  • 2024 International Congress

    Longitudinal Studies of LFP Activities During Acute and Chronic DBS Stimulation in PD Patients

    Y. Zhao, V. Rayudu, S. Santacruz, M. Varga (Austin, USA)

    Objective: This study investigates the changes in local field potential (LFP) during acute and chronic deep brain stimulation (DBS) in patients with Parkinson's disease (PD)…
  • 2024 International Congress

    Clinical, Neurophysiological, and Biological Insights into Levodopa-Induced Dyskinesias

    B. Angeloni, A T. Cimmino, R. Di Iorio, P. Calabresi, G. Di Lazzaro (Rome, Italy)

    Objective: The aim of this study was to determine the clinical, neurophysiological and biological features of Parkinson's Disease (PD) patients with L-Dopa-induced dyskinesias (LIDs). Background:…
  • « Previous Page
  • 1
  • …
  • 213
  • 214
  • 215
  • 216
  • 217
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley